Judicial Panel on Multidistrict Litigation, there were 3,848 gastroparesis and other stomach and GI related cases in the GLP-1 gastrointestinal injury MDL and 146 NAION cases in the GLP-1 eye injury vision loss MDL, as of July 1, 2026
The permeation enhancer field remained active throughout this period, but no single enhancer proved sufficient to achieve therapeutically meaningful oral bioavailability for GLP-1 peptides in clinical development
What about the thyroid warning
It reduces lean body weight
In this guide, well explore nutrition strategies to optimize your results and address common side effects of GLP-1 medications
If you want to see whether a personalized treatment path is right for you, you can complete the free assessment quiz